On ECHEMI
Home > Drugs > Tianjin Lisheng Pharmaceutical Co., Ltd.

Tianjin Lisheng Pharmaceutical Co., Ltd.

  • Founded in:

    1981-06-17
  • Country:

    China China
  • Address:

    No. 16, Saida North 1st Road, Xiqing Economic Development Zone, Tianjin
  • Tax NO.:

    91120000103069502J
  • Registered Funds:

    257.942988 yuan
  • Website:

  • Email:

Related Drugs
Formoterol Fumarate
Name Description Content CAS NO. Registered Holders
Formoterol fumarate dihydrate

183814-30-4 33
Formoterol Fumarate Tablets
The main ingredient of this product is: Formoterol fumarate.
Name Description Content CAS NO. Registered Holders
Formoterol fumarate dihydrate

This product is a long-acting selective adrenaline beta 2 receptor agonist with a dose-dependent bronchodilator effect. It can increase the forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PER). After taking 80 mu g of this product orally, the dilation effect is the strongest 4 hours later, and its effect is equivalent to that of taking 4 mg of salbutamol orally, but the effect is long-lasting. This product also has an antihistamine effect, which can inhibit the release of histamine from lung mast cells. Its effect is similar to that of histamine H1-receptor antagonists and mast cell stabilizers such as ketotifen.

More

This product is a long-acting selective adrenaline beta 2 receptor agonist with a dose-dependent bronchodilator effect. It can increase the forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PER). After taking 80 mu g of this product orally, the dilation effect is the strongest 4 hours later, and its effect is equivalent to that of taking 4 mg of salbutamol orally, but the effect is long-lasting. This product also has an antihistamine effect, which can inhibit the release of histamine from lung mast cells. Its effect is similar to that of histamine H1-receptor antagonists and mast cell stabilizers such as ketotifen.

183814-30-4 33
Norethindrone dripping pills
Each pill of this product contains 3 mg of the main ingredient, norethindrone.
Name Description Content CAS NO. Registered Holders
Norethindrone

This product is a progestogen drug that has the effect of inhibiting ovulation

More

This product is a progestogen drug that has the effect of inhibiting ovulation

3mg 68-22-4 18
Itraconazole capsules
The main ingredient of this product is itraconazole, its chemical name: cis-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazolyl-1-methyl)-1,3-dioxolane-4-]-methoxy]phenyl]-1-piperazinyl]-phenyl]-2,4-dihydro-2-(-1-methylpropyl)-3H-1,2,4-triazol-3-one
Name Description Content CAS NO. Registered Holders
Itraconazole

This product is a synthetic broad-spectrum antifungal drug, a triazole derivative, which is effective against dermatophytes (Trichophyton, Microsporum, Epidermophyton floccosum), yeasts [Cryptococcus neoformans, Pityrosporum, Candida (including Candida albicans, Candida glabrata and Candida krusei)], Aspergillus, Histoplasma, Paracoccidioides brasiliensis, Sporothrix schenckii, Chromatids, Cladosporium, Blastomyces dermatitidis and various other yeast and fungal infections. In vitro studies have confirmed that this product can inhibit the synthesis of ergosterol, one of the main components of fungal cell membranes, thereby exerting an antifungal effect.

More

This product is a synthetic broad-spectrum antifungal drug, a triazole derivative, which is effective against dermatophytes (Trichophyton, Microsporum, Epidermophyton floccosum), yeasts [Cryptococcus neoformans, Pityrosporum, Candida (including Candida albicans, Candida glabrata and Candida krusei)], Aspergillus, Histoplasma, Paracoccidioides brasiliensis, Sporothrix schenckii, Chromatids, Cladosporium, Blastomyces dermatitidis and various other yeast and fungal infections. In vitro studies have confirmed that this product can inhibit the synthesis of ergosterol, one of the main components of fungal cell membranes, thereby exerting an antifungal effect.

84625-61-6 41
Aluminum Magnesium Alginate Granules
This product is a compound preparation. Each 1000g contains 250g of alginate, 50g of aluminum hydroxide, 125g of magnesium trisilicate and an appropriate amount of flavoring agent.
Name Description Content CAS NO. Registered Holders
Alginic acid

Forms a gas-filled foam layer on the stomach surface, which physically blocks gastroesophageal acid reflux and protects the lower esophageal mucosa

More

Forms a gas-filled foam layer on the stomach surface, which physically blocks gastroesophageal acid reflux and protects the lower esophageal mucosa

250g 9005-32-7 4
Aluminum hydroxide

It plays an auxiliary therapeutic role by protecting the gastric and esophageal mucosa from the invasion of gastric acid.

More

It plays an auxiliary therapeutic role by protecting the gastric and esophageal mucosa from the invasion of gastric acid.

50g 21645-51-2 14
Magnesium trisilicate

It plays an auxiliary therapeutic role by protecting the gastric and esophageal mucosa from the invasion of gastric acid.

More

It plays an auxiliary therapeutic role by protecting the gastric and esophageal mucosa from the invasion of gastric acid.

125g 14987-04-3 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.